From: Eosinophils and other peripheral blood biomarkers in glioma grading: a preliminary study
Parameter | Median/Mean (IQR/SD) | Patient number | Percentage |
---|---|---|---|
Sex | |||
 Male | – | 224 | 62.2% |
 Female | – | 136 | 37.8% |
Glioma grade | |||
 LGG | – | 165 | 45.8% |
 HGG | – | 195 | 54.2% |
GBM status | |||
 Non-GBM |  | 254 | 70.6% |
 GBM |  | 106 | 29.4% |
Age (years) | 41 (33–50) |  |  |
Eo (×109/L) | 0.07 (0.04–0.12) |  |  |
Neu (× 109/L) | 4.23 (3.31–5.44) |  |  |
Mono (× 109/L) | 0.39 (0.30–0.50) |  |  |
Ly (× 109/L) | 1.83 (1.53–2.30) |  |  |
PLT (× 109/L) | 221 (187.25–265.00) |  |  |
ELR | 0.039 (0.022–0.065) |  |  |
NLR | 2.223 (1.629–3.189) |  |  |
MLR | 0.21 (0.16–0.26) |  |  |
PLR | 119.383 (93.148–150.950) |  |  |
Alb (g/L) | 46.300 (44.200–48.000) |  |  |
Glb (g/L) | 26.800 (24.300–29.000) |  |  |
Fbg (g/L) | 2.665 (2.250–3.110) |  |  |
PNI | 55.879 ± 4.680 |  |  |
SII | 526.938 (344.974–719.950) |  |  |